MAPT and tauopathy: Work with aggregated recombinant tau, conditioned media from tauopathy mouse neurons and human cerebrospinal fluid (CSF), has confirmed this prion‐like activity for most tauopathies (Boluda et al., 2015; Clavaguera et al., 2013).